Currently Viewing:
Supplements Understanding the Diagnosis, Management, and Treatment Options for Neurogenic Orthostatic Hypoten

Managed Care Approach to the Treatment of Neurogenic Orthostatic Hypotension



Publishing Staff  
Senior Vice President of Operations and Clinical Affairs
Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager
Ida Delmendo

Clinical Projects Manager
Cindy Spielvogel

Project Director
Christina Doong

Proofreaders
Maggie Shaw
Griselda Demassey


Associate Editor
Jeanne Linke

Clinical Editor
Michael R. Page, PharmD, RPh

Designer
Julianne Costello

Associate Publisher
Justin Gallagher 

Director of Sales 
Sara Stewart

National Account Managers 
Gabrielle Consola
Michael Costella


Corporate Chairman and CEO
Mike Hennessy, Sr

Vice Chairman
Jack Lepping

Chief Operating Officer/CFO
Neil Glasser, CPA/CFE

President, Managed Markets
Brian Haug

Executive Vice President and General Manager
John Maglione

Human Resources Director
Shari Lundenberg

Chief Creative Officer
Jeff Brown

President of Pharmacy Times Office of Continuing Professional Education
David Heckard

Participating Faculty
Faculty


Phillip A. Low, MD
Professor Department of Neurology
Mayo Clinic
Rochester, Minnesota

Stuart H. Isaacson, MD
Director Parkinson’s Disease and Movement Disorders Center of Boca Raton
Associate Professor of Neurology
Florida International University
Herbert Wertheim College of Medicine
Boca Raton, Florida


Editorial Support
Jill E. Allen, PharmD, BCPS
Drug Information Consultant
Pin Oak Associates
Salt Lake City, Utah


Faculty Disclosures
Phillip A. Low, MD, has no relevant commercial financial relationships or affiliations to disclose.

Stuart H. Isaacson, MD, has the following relevant commercial  financial relationships or affiliations to disclose:
Grant/Research Support:  Abbvie, Acadia, Acorda, Adamas, Addex, Amarantus, Auspex, Biotie, Cynapsus, Eisai, GE Healthcare, Ipsen, Kyowa, Lundbeck, Merz, Novartis, Neurocrine, Pfizer, Pharma2B, Roche, Santhera, Serono, Shire, Teva, UCB, US World Meds, Xenoport Consultant:  Acadia, Acorda, Allergan, Amarantus, Auspex, Biotie, Britannia, Cynapsus, Eisai, GE Healthcare, Impax, Ipsen, Kyowa, Lundbeck, Teva, UCB, US World Meds, Xenoport Speaker’s Bureau:  Abbvie, Acadia, Allergan, GE Healthcare, Impax, Lundbeck, Teva, UCB, US World Meds, Xenoport


Editorial Support Disclosures
Jill E. Allen, PharmD, BCPS, has no relevant commercial financial relationships or affiliations to disclose.

The American Journal of Managed Care
Publishing Staff
—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education
Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Donna Fausak; and Nathalie Harden have no relevant financial relationships with commercial interests to disclose.







PDF
 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!